Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Papers
(The H4-Index of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Correction34
Clinical and demographical characteristics in a cohort of MND patients treated with riluzole. Differences between tablets and oral suspension32
Incorporating patient preferences and burden-of-disease in evaluating ALS drug candidate AMX0035: a Bayesian decision analysis perspective30
Development, reliability, validity, and acceptability of the remote administration of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)30
The correlation between social support, coping style, advance care planning readiness, and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study25
Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS)25
Rapid classification of a novel ALS-causing I149S variant in superoxide dismutase-125
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: a ten year follow up study24
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure23
Single task-level, 2SD-based cutoffs for the Italian version of the Edinburgh Cognitive and Behavioral ALS screen (ECAS)22
Theme 5 Human Cell Biology and Pathology21
Genetic ancestry and risk allele C9orf72 rs3849942 T for amyotrophic lateral sclerosis in Latin American populations20
Impact of occupational categories on the incidence of amyotrophic lateral sclerosis in Sardinia Island, Italy20
Challenges in medical care for amyotrophic lateral sclerosis: a survey of physicians from Republic of Bashkortostan (Russia), Belarus, and Kazakhstan19
Residential exposure associations with ALS risk, survival, and phenotype: a Michigan-based case-control study19
Theme 7 Pre-Clinical Therapeutic Strategies18
Incidence of amyotrophic lateral sclerosis before and during the COVID-19 pandemic: evidence from an 8-year population-based study in Central Italy based on healthcare utilization databases17
Emerging strategies for interpreting variants of uncertain significance (VUS) in amyotrophic lateral sclerosis17
0.15190982818604